Every medical term used across this site, defined in plain language. Terms are listed alphabetically.
A
- Adjuvant therapy
- Additional treatment given after the primary surgery — such as chemotherapy, irradiation or hormonal therapy — to reduce the risk of recurrence.
- Areola
- The circular pigmented skin surrounding the nipple.
- Aspiration
- Removing fluid or cells with a needle; a cyst aspiration empties a fluid-filled sac, while fine needle aspiration collects cells from a mass.
- Atypical hyperplasia
- An overgrowth of cells lining the breast ducts or lobules with abnormal appearance under the microscope; associated with a 4.5–5 fold increase in breast cancer risk.
- Axilla / axillary nodes
- The armpit and its lymph nodes; nodal status is the most important prognostic indicator in breast cancer.
B
- Benign
- Not cancer; a benign growth does not invade surrounding tissue or spread elsewhere.
- Biopsy
- Removal of cells or tissue for microscopic examination — by fine needle, core needle (stereotactic or sonography-guided) or open surgery.
- BRCA1 / BRCA2
- Genes which, when mutated, increase the risk of breast, ovarian and other epithelial cancers.
C
- Calcification
- Tiny calcium deposits in the breast; certain mammographic patterns can suggest cancer.
- Chemoprevention
- Using medication such as tamoxifen or raloxifene to reduce the risk of developing breast cancer.
- Chemotherapy
- Drug treatment that acts throughout the body (systemic therapy) to kill cancer cells.
- Comedo
- A subtype of ductal carcinoma in situ whose cut surface extrudes necrotic cells like a blackhead; generally more aggressive than non-comedo types.
- Core biopsy
- A needle biopsy removing a small cylinder of tissue, guided by stereotactic mammography or by ultrasound.
- Cyst
- A fluid-filled sac in the breast; a simple cyst is benign.
D
- Duct
- A channel carrying milk from the lobule to the nipple; ten to fifteen ducts open on the surface of the nipple.
- Ductal carcinoma in situ (DCIS)
- Early breast cancer confined to the inside of the ductal system.
F–H
- Estrogen / progesterone receptors
- Protein binding sites on tumor cells; their presence predicts response to hormonal therapy and a better prognosis.
- Fat necrosis
- A firm, benign mass that usually follows breast trauma; can mimic cancer on examination and mammography.
- Fibroadenoma
- A common benign solid breast tumor, typical of adolescence and young adulthood.
- Fibrocystic changes
- The normal cyclic changes of the breast — cysts, fibrosis and proliferative lesions — present in 90% of women.
- Fine needle aspiration biopsy (FNAB)
- A small-needle biopsy collecting cells from a mass; a malignant result is 100% accurate, a benign one only 64% accurate.
- Galactorrhea
- Milky nipple discharge outside of breastfeeding; can be associated with thyroid or pituitary conditions or medications.
- Galactography
- X-ray imaging of the milk ducts after injection of contrast, used to evaluate single-duct discharge.
- Histologic grade
- How abnormal the tumor cells look under the microscope; survival decreases as grade increases.
- Hyperplasia
- An increased number of cell layers lining the ducts or lobules; without atypia it carries a slight risk increase (1.5–2 fold).
I–M
- Inflammatory carcinoma
- An aggressive cancer presenting with red, thickened, orange-peel-like breast skin (peau d’orange).
- Intraductal papilloma
- A benign growth inside a milk duct, a common cause of single-duct nipple discharge.
- Invasive (infiltrating) carcinoma
- Cancer that has spread beyond the duct or lobule into surrounding tissue; infiltrating ductal carcinoma is the most common type (78%).
- Lactating adenoma
- A benign breast tumor similar to a fibroadenoma, appearing during pregnancy or lactation.
- Lobular carcinoma in situ (LCIS)
- A benign proliferative change that marks increased breast cancer risk (15–35% over fifteen years) despite its name.
- Lobule
- A group of milk-producing glands, arranged in the breast like the petals of a flower.
- Lumpectomy
- Removal of the tumor with a margin of normal tissue, preserving the breast; paired with irradiation in conservative breast surgery.
- Lymphedema
- Arm swelling caused by lymphatic obstruction after axillary surgery or irradiation.
- Malignant
- Cancerous — able to invade and spread to other organs (metastasize).
- Mastalgia
- Breast pain or tenderness, cyclic or non-cyclic; benign 90% of the time.
- Mastectomy
- Surgical removal of the breast; simple (breast only), modified radical (with axillary sampling) or, historically, radical (also removing chest wall muscles).
- Mammography
- Low-dose breast x-ray; about 85% accurate for cancer detection and reduces breast cancer mortality by 30–40%.
- Metastasis
- Spread of cancer to distant organs, most often bone, liver, lung or brain.
- Milk line
- The embryonic ridge from armpit to groin along which accessory breast tissue or nipples may persist in 2–6% of women.
N–V
- Peau d’orange
- Orange-peel skin texture caused by lymphatic blockage; a warning sign of inflammatory carcinoma.
- Prophylactic mastectomy
- Removal of a healthy breast to substantially reduce (but not eliminate) breast cancer risk in high-risk women.
- Sentinel node
- The first lymph node to receive drainage from a tumor; a negative sentinel node can spare the patient a full axillary dissection.
- Sonography (ultrasound)
- Sound-wave imaging that distinguishes cystic from solid masses and guides biopsy; cannot see microcalcifications.
- Stereotactic biopsy
- A computer-guided core biopsy targeting a lesion by its mammographic coordinates.
- Tamoxifen
- A hormonal (anti-estrogen) therapy used to treat breast cancer and to reduce risk in high-risk women by about 50%.
- Tumor
- An abnormal growth; may be benign or malignant.
- Virginal hypertrophy
- Asymmetric, excessive growth of one breast over the other during adolescence.
Looking for a term that is not here? Try the homepage guides or the FAQ.